Description de l'entreprise
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager.
Conseil d'administration & Conseil de surveillance
| PDG |
| Jim Hollingshead |
| Conseil d'administration |
| Wayde McMillan, Eric Benjamin, Lauren Budden, Laetitia Cousin, Patrick Crannell, Mark Field, Deborah Gordon, John Kapples, Dr. Trang Ly, Dan Manea, Prem Singh |
| Conseil de surveillance |
| Luciana Borio, Wayne A. I. Frederick, Jim Hollingshead, Jessica Hopfield, Michael R. Minogue, Corinne Nevinny, Shacey Petrovic, Timothy J. Scannell, Elizabeth Weatherman |
Données de l'entreprise
| Nom: |
Insulet Corporation |
| Adresse: |
100 Nagog Park,Acton, MA 01720 |
| Téléphone: |
(+1) 978-600-7000 |
| Fax: |
(+1) 978-600-0120 |
| Courriel: |
-
|
| Internet: |
https://www.insulet.com/ |
| Industrie: |
Healthcare |
| Secteur: |
Medical Products |
| Sous-secteur: |
- |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
- |
| IPO date: |
15/05/2007 |
Relations avec les investisseurs
| Nom: |
Deborah R. Gordon |
| Téléphone IR: |
- |
| IR-Fax: |
- |
| E-mail IR: |
ir@insulet.com
|
